Despite ongoing questions about its mRNA technology, Moderna has secured a $176 million U.S. government contract to develop a bird flu vaccine as concerns grow over the H5N1 virus spreading among dairy cows and workers. This funding will support advanced development and testing of the vaccine, with late-stage trials planned for 2025. While the risk to humans is currently low, scientists worry the virus could mutate. Moderna’s swift vaccine development capabilities, proven during the COVID-19 pl...